Skip to main content
SpringerLink
Log in

Guidelines on Radioisotope Treatment of Neuroendocrine Tumors

  • Chapter
  • First Online:
Clinical Applications of Nuclear Medicine Targeted Therapy

  • 980 Accesses

Abstract

The present chapter has the aim to provide the current position of radioimmunotherapy (RIT) for the treatment of neuroendocrine tumors (NETs), in the main national and international clinical guidelines. Table 24.1 reported a summary of clinical indications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Öberg K, Knigge U, Kwekkeboom D, Perren A, ESMO Guidelines Working Group. Neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii124–30.

    PubMed  Google Scholar 

  2. Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, North American Neuroendocrine Tumor Society, et al. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 2013;42:557–77.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bodei L, Mueller-Brand J, Baum RP, Pavel ME, Hörsch D, O’Dorisio MS, et al. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2013;40:800–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Singh S, Dev C, Kenneche H, Kocha W, Maroun J, Metrakos P, et al. Consensus recommendations for the diagnosis and management of pancreatic neuroendocrine tumors: guidelines from a Canadian National Expert Group. Ann Surg Oncol. 2015;22:2685–99.

    Article  PubMed  Google Scholar 

  5. Delle Fave G, O’Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, et al. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology. 2016;103:119–24.

    Article  CAS  PubMed  Google Scholar 

  6. Niederle B, Pape U-F, Costa F, Gross D, Kelestimur F, Knigge U, et al. ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum. Neuroendocrinology. 2016;103:125–38.

    Article  CAS  PubMed  Google Scholar 

  7. O’Toole D, Kianmanesh R, Caplin M. ENETS consensus guidelines update for management of patients with digestive neuroendocrine tumors: an update. Neuroendocrinology. 2016;103:117–8.

    Article  PubMed  Google Scholar 

  8. Dobson R, Vinjamuri S, Hsuan J, Banks M, Terlizzo M, Wieshmann H, et al. Treatment of orbital metastases from a primary midgut neuroendocrine tumor with peptide-receptor radiolabeled therapy using 177 lutetium-DOTATATE. J Clin Oncol. 2013;31:e272–5.

    Article  PubMed  Google Scholar 

  9. Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. NETTER-1 trial investigators. Phase 3 trial of 177lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125–35.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic of Radiology & Nuclear Medicine, Basel University Hospital, University of Basel, Basel, Switzerland

    Federico Caobelli

  2. Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy

    Laura Evangelista

Authors
  1. Federico Caobelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Evangelista
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Caobelli .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Humanitas Gavazzeni Hospital, Bergamo, Italy

    Emilio Bombardieri

  2. Nuclear Medicine Therapy and Endocrinology, Istituto Nazionale dei Tumori, Milano, Italy

    Ettore Seregni

  3. Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy

    Laura Evangelista

  4. Nuclear Medicine Division, Istituto Nazionale dei Tumori, Milano, Italy

    Carlo Chiesa

  5. Nuclear Medicine, Humanitas Research Hospital, Rozzano, Milano, Italy

    Arturo Chiti

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Caobelli, F., Evangelista, L. (2018). Guidelines on Radioisotope Treatment of Neuroendocrine Tumors. In: Bombardieri, E., Seregni, E., Evangelista, L., Chiesa, C., Chiti, A. (eds) Clinical Applications of Nuclear Medicine Targeted Therapy . Springer, Cham. https://doi.org/10.1007/978-3-319-63067-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63067-0_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63066-3

  • Online ISBN: 978-3-319-63067-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation